Peptic Ulcer Disease
Although the incidence and complications of peptic ulcer disease have declined, Helicobacter pylori infection and nonsteroidal anti-inflammatory drug use remain key risk factors. Advances in proton pump inhibitors and potassium-competitive acid blockers have improved treatment outcomes. However, inc...
Saved in:
Main Author: | Seung Han Kim |
---|---|
Format: | Article |
Language: | English |
Published: |
Korean College of Helicobacter and Upper Gastrointestinal Research
2025-03-01
|
Series: | The Korean Journal of Helicobacter and Upper Gastrointestinal Research |
Subjects: | |
Online Access: | http://helicojournal.org/upload/pdf/kjhugr-2024-0075.pdf |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Helicobacter pylori-negative Peptic Ulcer
by: Ji Hyun Song, et al.
Published: (2017-09-01) -
Helicobacter pylori Eradication in Patients with an Iatrogenic Ulcer after Endoscopic Resection and Peptic Ulcer
by: Seol So, et al.
Published: (2018-03-01) -
The Role of Helicobacter pylori Infection in Drug-induced Peptic Ulcer
by: Jin Sung Koh, et al.
Published: (2018-06-01) -
New Approaches to Therapy of Helicobacter pylori Infection (by the Materials of the Maastricht Consensus-IV, Florence, 2010)
by: A. G. Evdokimova, et al.
Published: (2020-05-01) -
Etiology and Therapeutic Strategies for Refractory Peptic Ulcers: A Comprehensive Review
by: Su Bee Park
Published: (2025-03-01)